Literature DB >> 17400900

Long-term treatment with carprofen of 805 dogs with osteoarthritis.

S Mansa1, E Palmér, C Grøndahl, L Lønaas, G Nyman.   

Abstract

The pain-relieving effect of carprofen and tolerance to the drug were investigated in 805 dogs that were lame as a result of osteoarthritis. The dogs were of different breeds, ages and bodyweights and of both sexes, and were selected from 51 veterinary clinics. Each dog was treated orally by its owner with 4 mg/kg carprofen for 84 consecutive days. Twenty-four dogs were removed from the study because of side effects, and 55 left the study for reasons unrelated to the treatment. The condition of the dogs and the benefit of the treatment were evaluated by the veterinary surgeons and the owners after 14 days, and at the end of the period of treatment, when 194 of the dogs (26.7 per cent) were no longer lame, and 357 (49.2 per cent) had improved. The period for which the dogs had been lame before entering the study significantly (P<0.01) affected the results and the rate of improvement. Too much exercise during the 84 days of treatment caused some dogs to relapse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400900     DOI: 10.1136/vr.160.13.427

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  8 in total

1.  Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis.

Authors:  M Payne-Johnson; C Becskei; Y Chaudhry; M R Stegemann
Journal:  Vet Rec       Date:  2014-11-27       Impact factor: 2.695

2.  Global positioning system derived performance measures are responsive indicators of physical activity, disease and the success of clinical treatments in domestic dogs.

Authors:  Elizabeth A Bruno; James W Guthrie; Stephen A Ellwood; Richard J Mellanby; Dylan N Clements
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

3.  Intra-Articular Hyaluronic Acid Compared to Traditional Conservative Treatment in Dogs with Osteoarthritis Associated with Hip Dysplasia.

Authors:  Gabriel O L Carapeba; Poliana Cavaleti; Gabriel M Nicácio; Rejane B Brinholi; Rogério Giuffrida; Renata N Cassu
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-26       Impact factor: 2.629

4.  A complete cross-over design evaluating canine acceptance of Carprieve® and Rimadyl® carprofen chewable tablets in healthy dogs.

Authors:  Diana M A Dewsbury; Keith D DeDonder; Darrell J Rezac; Natalia Cernicchiaro
Journal:  BMC Vet Res       Date:  2019-11-05       Impact factor: 2.741

5.  Efficacy of a dietary supplement in dogs with osteoarthritis: A randomized placebo-controlled, double-blind clinical trial.

Authors:  Elisa Martello; Mauro Bigliati; Raffaella Adami; Elena Biasibetti; Donal Bisanzio; Giorgia Meineri; Natascia Bruni
Journal:  PLoS One       Date:  2022-02-16       Impact factor: 3.240

Review 6.  Challenges with Assessing and Treating Pain in Research Primates: A Focused Survey and Literature Review.

Authors:  Emilie A Paterson; Patricia V Turner
Journal:  Animals (Basel)       Date:  2022-09-05       Impact factor: 3.231

7.  Enflicoxib for canine osteoarthritis: A randomized, blind, multicentre, non-inferiority clinical trial compared to mavacoxib.

Authors:  Marta Salichs; Llorenç Badiella; Patxi Sarasola; Josep Homedes
Journal:  PLoS One       Date:  2022-09-20       Impact factor: 3.752

8.  Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis.

Authors:  Sarah Malek; Susannah J Sample; Zeev Schwartz; Brett Nemke; Peer B Jacobson; Elizabeth M Cozzi; Susan L Schaefer; Jason A Bleedorn; Gerianne Holzman; Peter Muir
Journal:  BMC Vet Res       Date:  2012-10-04       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.